EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cefiderocol Is an Effective Topical Monotherapy for Experimental Extensively Drug-Resistant Pseudomonas aeruginosa Keratitis

Eric G Romanowski, Sonya M Mumper, Hazel Q Shanks, Kathleen A Yates, Jonathan B Mandell, Michael E Zegans, Robert M Q Shanks

Ophthalmology Science · 2024-07 · 4 (4) · 100452

DOI: 10.1016/j.xops.2023.100452 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Ophthalmology Science, 2024-07. Verfasst von Eric G Romanowski und 6 weiteren Autor:innen. Beteiligte Einrichtung: Charles T. Campbell Laboratory of Ophthalmic Microbiology, Department of Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, Penn…. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NEI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To test cefiderocol, a siderophore-cephalosporin antibiotic for topical monotherapy treatment of experimental extensively drug-resistant (XDR) Pseudomonas aeruginosa keratitis.

Design

Preclinical study. Subjects and Controls: Deidentified P. aeruginosa keratitis isolates, XDR P. aeruginosa from eye drop outbreak, rabbits, saline, cefiderocol 50 mg/ml, ciprofloxacin 0.3%, and tobramycin 14 mg/ml.

Methods

Intervention or Testing: Cefiderocol antibacterial activity against P. aeruginosa keratitis isolates (n = 135) was evaluated by minimum inhibitory concentration (MIC) testing. Ocular toxicity/tolerability and antibacterial efficacy were tested in vivo with experimental rabbit models. Corneal concentrations and stability were assessed using a bioassay. Main Outcome Measures: Minimum inhibitory concentration analysis for susceptibility, graded tests for ocular toxicity/tolerability, colony-forming unit (CFU) analysis for bacterial burden, corneal cefiderocol concentrations.

Results

One hundred percent of P. aeruginosa keratitis isolates were susceptible to cefiderocol (n = 135), the MIC90 was 0.125 μg/ml including the XDR isolate (MIC = 0.125 μg/ml). Topical cefiderocol 50 mg/ml was minimally toxic to the ocular surface and was well tolerated. For the XDR P. aeruginosa isolate, topical cefiderocol 50 mg/ml, significantly decreased corneal CFU compared with ciprofloxacin 0.3%, tobramycin 14 mg/ml, and saline. In addition, tobramycin 14 mg/ml was more effective than the saline control. Mean cefiderocol corneal concentrations were 191× greater than the MIC90 of the P. aeruginosa keratitis isolates. Refrigerated cefiderocol maintained antimicrobial activity over a 1-month period.

Conclusions

These results demonstrate that cefiderocol is well tolerated on rabbit corneas and is effective against P. aeruginosa keratitis isolates in vitro and was effective in vivo against an XDR isolate in a rabbit keratitis model. Given the recent outbreak of keratitis caused by this XDR P. aeruginosa, cefiderocol is a promising additional antibiotic that should be further evaluated for topical treatment of keratitis caused by antibiotic resistant P. aeruginosa. Financial Disclosures: Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.

Schlagwörter

Stichwörter der Autor:innen

Antibiotic resistanceCefiderocolKeratitisOcular infectionPseudomonas aeruginosa

Autor:innen und Institutionen

  • Charles T. Campbell Laboratory of Ophthalmic Microbiology, Department of Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
  • Department of Surgery, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire.
  • Department of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire.

Förderung

  • NEI NIH HHS

Zitieren

APA

Romanowski, E. G., Mumper, S. M., Shanks, H. Q., Yates, K. A., Mandell, J. B., Zegans, M. E., & Shanks, R. M. Q. (2024). Cefiderocol Is an Effective Topical Monotherapy for Experimental Extensively Drug-Resistant Pseudomonas aeruginosa Keratitis. Ophthalmology Science, 4(4), 100452. https://doi.org/10.1016/j.xops.2023.100452

Vancouver

Romanowski EG, Mumper SM, Shanks HQ, Yates KA, Mandell JB, Zegans ME, et al. Cefiderocol Is an Effective Topical Monotherapy for Experimental Extensively Drug-Resistant Pseudomonas aeruginosa Keratitis. Ophthalmology Science. 2024;4(4):100452. doi:10.1016/j.xops.2023.100452

BibTeX
@article{Romanowski2024,
  author = {Romanowski, Eric G and Mumper, Sonya M and Shanks, Hazel Q and Yates, Kathleen A and Mandell, Jonathan B and Zegans, Michael E and Shanks, Robert M Q},
  title = {Cefiderocol Is an Effective Topical Monotherapy for Experimental Extensively Drug-Resistant Pseudomonas aeruginosa Keratitis},
  journal = {Ophthalmology Science},
  year = {2024},
  volume = {4},
  number = {4},
  pages = {100452},
  doi = {10.1016/j.xops.2023.100452}
}
Kostenlos starten →